Recent research indicates that colon cancer patients with circulating tumor DNA post-surgery may improve their survival likelihood with daily celecoxib use. Celecoxib, a COX-2 inhibitor, significantly ...
Patients with colon cancer who still have cancer cells in their blood after surgery may improve their survival odds with ...
15h
Vertex Pharmaceuticals Inc. (VRTX) has secured FDA approval for Suzetrigine, an oral, non-opioid, highly selective NaV1.8 pain signal ...
The U.S. Food and Drug Administration (FDA) on Thursday approved Journavx, the first new class of pain medication in more ...
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
A study finds that celecoxib improves disease-free survival in stage 3 colon cancer patients with positive ctDNA after ...
News Medical on MSN4d
Blood test for ctDNA identifies patients who benefit from celecoxib after surgeryA data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham ...
Although ctDNA positivity generally meant worse disease-free survival in stage 3 resected colon cancer, patients with ctDNA ...
The Alliance for Clinical Trials in Oncology today announced the results of a data analysis from a randomized phase III ...
The Alliance for Clinical Trials in Oncology today announced the results of a data analysis from a randomized phase III clinical trial involving patients with stage III colon cancer, which found that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback